A Glance at Gene Therapy Advances in Cancer
In the virtual ASGCT21 meeting, a panel discussion focused on the preclinical and clinical updates of gene therapy interventions in cancer. Co-chairs Rayne Rouce, M.D., and Renata Stripecke, Ph.D., moderated a conversation on the latest developments in cancer therapies.
The panelists comprised of:
Jack Roth, M.D., University of Texas MD Anderson Cancer Center Marcela Maus, M.D., Ph.D., Massachusetts General Hospital Paola Grandi, Ph.D., CG Oncology Cliona Rooney, Ph.D., Baylor College of Medicine
The panelists comprised of:
Jack Roth, M.D., University of Texas MD Anderson Cancer Center Marcela Maus, M.D., Ph.D., Massachusetts General Hospital Paola Grandi, Ph.D., CG Oncology Cliona Rooney, Ph.D., Baylor College of Medicine
GO Prime with only $1.49 now
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02